The agreement spans feed, hatcheries, farming, processing, cold chain and distribution.
The company had previously announced plans to acquire 65% of EL.VI.Z, with a further 35% stake planned to be acquired within three years.
The site is the company’s first ground-up factory in more than 50 years.
The acquisition expands access to local grain and strengthens Kalmbach’s feed, pet food and ingredient operations.
The solar-powered, off-grid facility can store about 40 million vaccine doses, helping protect them from power outages.
The ambition highlights the need to strengthen Ethiopia’s local feed manufacturing capacity as poultry production expands.
The interim financing was oversubscribed with participation from private investors, family offices, and venture capital across the UK, Norway, and the European Union.
The funding will launch Maash’s French demo plant and support industrial-scale production of its LoCylia mycoprotein.
The project was officially opened on August 5, with representatives from Imas attending the ceremony.
Haid is investing in local production capacity in markets where livestock and aquaculture sectors are expanding.